Michael Kiernan to Registries
This is a "connection" page, showing publications Michael Kiernan has written about Registries.
Connection Strength
1.064
-
Gulati G, Tsoi MR, Upshaw JN, Vest AR, DeNofrio D, Kiernan MS. The Association Between Pulmonary Vascular Resistance and Posttransplant Outcomes Differs by Left Ventricular Assist Device Status. ASAIO J. 2025 Mar 01; 71(3):222-228.
Score: 0.169
-
Grandin EW, Gulati G, Nunez JI, Kennedy K, Rame JE, Atluri P, Pagani FD, Kirklin JK, Kormos RL, Teuteberg J, Kiernan MS. Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis. Circ Heart Fail. 2022 04; 15(4):e008613.
Score: 0.142
-
Rame JE, Pagani FD, Kiernan MS, Oliveira GH, Birati EY, Atluri P, Gaffey A, Grandin EW, Myers SL, Collum C, Kormos RL, Kirklin JK, Teuteberg JJ. Evolution of Late Right Heart?Failure With Left Ventricular Assist Devices and Association?With?Outcomes. J Am Coll Cardiol. 2021 12 07; 78(23):2294-2308.
Score: 0.140
-
Brinkley DM, Wang L, Yu C, Grandin EW, Kiernan MS. Impact of renin-angiotensin-aldosterone system inhibition on morbidity and mortality during long-term continuous-flow left ventricular assist device support: An IMACS report. J Heart Lung Transplant. 2021 12; 40(12):1605-1613.
Score: 0.137
-
Molina EJ, Shah P, Kiernan MS, Cornwell WK, Copeland H, Takeda K, Fernandez FG, Badhwar V, Habib RH, Jacobs JP, Koehl D, Kirklin JK, Pagani FD, Cowger JA. The Society of Thoracic Surgeons Intermacs 2020 Annual Report. Ann Thorac Surg. 2021 03; 111(3):778-792.
Score: 0.131
-
Brinkley DM, DeNofrio D, Ruthazer R, Vest AR, Kapur NK, Couper GS, Kiernan MS. Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as Destination Therapy at Transplant Versus Nontransplant Centers. Circ Heart Fail. 2018 03; 11(3):e004384.
Score: 0.107
-
Kiernan MS, Grandin EW, Brinkley M, Kapur NK, Pham DT, Ruthazer R, Rame JE, Atluri P, Birati EY, Oliveira GH, Pagani FD, Kirklin JK, Naftel D, Kormos RL, Teuteberg JJ, DeNofrio D. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail. 2017 Oct; 10(10).
Score: 0.104
-
Khazanie P, Hammill BG, Patel CB, Kiernan MS, Cooper LB, Arnold SV, Fendler TJ, Spertus JA, Curtis LH, Hernandez AF. Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS. J Card Fail. 2016 Sep; 22(9):672-9.
Score: 0.093
-
Vest AR, Price LL, Chanda A, Sweigart BA, Chery J, Lawrence M, Parsly L, Gulati G, Kiernan MS, Upshaw JN, Kawabori M, Couper GS, Saltzman E. Cardiac Cachexia in Left Ventricular Assist Device Recipients and the Implications of Weight Gain Early After Implantation. J Am Heart Assoc. 2023 07 04; 12(13):e029086.
Score: 0.039